Ophthalmic Consultants of Boston   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Boston MA United States (1969)

Organization Overview

First Clinical Trial
2005
NCT00395551
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Jeffrey S Heier | Ophthalmic Consultants of Boston